Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119232) titled 'Dermal safety Assessment of the product on participants skin' on Oct. 9.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Outcome Assessor Blinded
Primary Sponsor: Smart Laboratories Pvt Ltd
Intervention:
Intervention1: MOISTFIX MAX LOTION
: Route of administration Topical mode of usage Products will be evaluated through the complete occlusion patch application for 24hours At 24 hours post application patches will be removed and skin will be assessed for irritation r...